Cargando…
Cannabinoid CB2 receptors are upregulated via bivalent histone modifications and control primary afferent input to the spinal cord in neuropathic pain
Type-2 cannabinoid receptors (CB2, encoded by the Cnr2 gene) are mainly expressed in immune cells, and CB2 agonists normally have no analgesic effect. However, nerve injury upregulates CB2 in the dorsal root ganglion (DRG), following which CB2 stimulation reduces neuropathic pain. It is unclear how...
Autores principales: | Ghosh, Krishna, Zhang, Guang-Fen, Chen, Hong, Chen, Shao-Rui, Pan, Hui-Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168157/ https://www.ncbi.nlm.nih.gov/pubmed/35500651 http://dx.doi.org/10.1016/j.jbc.2022.101999 |
Ejemplares similares
-
Modeling the Dynamics of Bivalent Histone Modifications
por: Ku, Wai Lim, et al.
Publicado: (2013) -
Protective role of neuronal and lymphoid cannabinoid CB(2) receptors in neuropathic pain
por: Cabañero, David, et al.
Publicado: (2020) -
Bivalent histone modifications during tooth development
por: Zheng, Li-Wei, et al.
Publicado: (2014) -
Local activation of cannabinoid CB(1 )receptors in the urinary bladder reduces the inflammation-induced sensitization of bladder afferents
por: Walczak, Jean-Sébastien, et al.
Publicado: (2011) -
Developmental and Visual Input-Dependent Regulation of the CB1 Cannabinoid Receptor in the Mouse Visual Cortex
por: Yoneda, Taisuke, et al.
Publicado: (2013)